PL356846A1 - Zastosowanie antagonistów interleukiny-6 do leczenia chorób scharakteryzowanych przez wysoki poziomaromatazy - Google Patents

Zastosowanie antagonistów interleukiny-6 do leczenia chorób scharakteryzowanych przez wysoki poziomaromatazy

Info

Publication number
PL356846A1
PL356846A1 PL00356846A PL35684600A PL356846A1 PL 356846 A1 PL356846 A1 PL 356846A1 PL 00356846 A PL00356846 A PL 00356846A PL 35684600 A PL35684600 A PL 35684600A PL 356846 A1 PL356846 A1 PL 356846A1
Authority
PL
Poland
Prior art keywords
antagonists
treatment
aromatase
interleukin
high levels
Prior art date
Application number
PL00356846A
Other languages
English (en)
Inventor
Michael John Reed
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL356846A1 publication Critical patent/PL356846A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/204—IL-6
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
PL00356846A 2000-03-06 2000-03-06 Zastosowanie antagonistów interleukiny-6 do leczenia chorób scharakteryzowanych przez wysoki poziomaromatazy PL356846A1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IT2000/000072 WO2001066131A1 (en) 2000-03-06 2000-03-06 Use of interleukin-6 antagonists for the treatment of diseases characterised by high levels of aromatase

Publications (1)

Publication Number Publication Date
PL356846A1 true PL356846A1 (pl) 2004-07-12

Family

ID=11133493

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00356846A PL356846A1 (pl) 2000-03-06 2000-03-06 Zastosowanie antagonistów interleukiny-6 do leczenia chorób scharakteryzowanych przez wysoki poziomaromatazy

Country Status (17)

Country Link
US (1) US7160860B2 (pl)
EP (1) EP1261367B1 (pl)
JP (1) JP2003525906A (pl)
KR (1) KR100694005B1 (pl)
AT (1) ATE295735T1 (pl)
AU (1) AU2000233235A1 (pl)
CA (1) CA2400711A1 (pl)
CZ (1) CZ20022760A3 (pl)
DE (1) DE60020269T2 (pl)
DK (1) DK1261367T3 (pl)
ES (1) ES2241583T3 (pl)
HU (1) HUP0300117A3 (pl)
MX (1) MXPA02008697A (pl)
PL (1) PL356846A1 (pl)
PT (1) PT1261367E (pl)
SK (1) SK12412002A3 (pl)
WO (1) WO2001066131A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6793678B2 (en) 2002-06-27 2004-09-21 Depuy Acromed, Inc. Prosthetic intervertebral motion disc having dampening
US8105382B2 (en) 2006-12-07 2012-01-31 Interventional Spine, Inc. Intervertebral implant
US8900307B2 (en) 2007-06-26 2014-12-02 DePuy Synthes Products, LLC Highly lordosed fusion cage
EP2471493A1 (en) 2008-01-17 2012-07-04 Synthes GmbH An expandable intervertebral implant and associated method of manufacturing the same
JP5441997B2 (ja) 2008-04-05 2014-03-12 ジンテス ゲゼルシャフト ミット ベシュレンクテル ハフツング 拡張可能な椎骨間インプラント
US9526620B2 (en) 2009-03-30 2016-12-27 DePuy Synthes Products, Inc. Zero profile spinal fusion cage
US9393129B2 (en) 2009-12-10 2016-07-19 DePuy Synthes Products, Inc. Bellows-like expandable interbody fusion cage
US9282979B2 (en) 2010-06-24 2016-03-15 DePuy Synthes Products, Inc. Instruments and methods for non-parallel disc space preparation
US8979860B2 (en) 2010-06-24 2015-03-17 DePuy Synthes Products. LLC Enhanced cage insertion device
EP2588034B1 (en) 2010-06-29 2018-01-03 Synthes GmbH Distractible intervertebral implant
US9402732B2 (en) 2010-10-11 2016-08-02 DePuy Synthes Products, Inc. Expandable interspinous process spacer implant
US8518087B2 (en) 2011-03-10 2013-08-27 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8394129B2 (en) 2011-03-10 2013-03-12 Interventional Spine, Inc. Method and apparatus for minimally invasive insertion of intervertebral implants
US8940052B2 (en) 2012-07-26 2015-01-27 DePuy Synthes Products, LLC Expandable implant
US9717601B2 (en) 2013-02-28 2017-08-01 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9522070B2 (en) 2013-03-07 2016-12-20 Interventional Spine, Inc. Intervertebral implant
US11426290B2 (en) 2015-03-06 2022-08-30 DePuy Synthes Products, Inc. Expandable intervertebral implant, system, kit and method
US9913727B2 (en) 2015-07-02 2018-03-13 Medos International Sarl Expandable implant
JP7023877B2 (ja) 2016-06-28 2022-02-22 イーアイティー・エマージング・インプラント・テクノロジーズ・ゲーエムベーハー 拡張可能かつ角度調節可能な関節運動式の椎間ケージ
US11510788B2 (en) 2016-06-28 2022-11-29 Eit Emerging Implant Technologies Gmbh Expandable, angularly adjustable intervertebral cages
US10537436B2 (en) 2016-11-01 2020-01-21 DePuy Synthes Products, Inc. Curved expandable cage
US10888433B2 (en) 2016-12-14 2021-01-12 DePuy Synthes Products, Inc. Intervertebral implant inserter and related methods
US10398563B2 (en) 2017-05-08 2019-09-03 Medos International Sarl Expandable cage
US11344424B2 (en) 2017-06-14 2022-05-31 Medos International Sarl Expandable intervertebral implant and related methods
US10940016B2 (en) 2017-07-05 2021-03-09 Medos International Sarl Expandable intervertebral fusion cage
US11446156B2 (en) 2018-10-25 2022-09-20 Medos International Sarl Expandable intervertebral implant, inserter instrument, and related methods
US11426286B2 (en) 2020-03-06 2022-08-30 Eit Emerging Implant Technologies Gmbh Expandable intervertebral implant
US11850160B2 (en) 2021-03-26 2023-12-26 Medos International Sarl Expandable lordotic intervertebral fusion cage
US11752009B2 (en) 2021-04-06 2023-09-12 Medos International Sarl Expandable intervertebral fusion cage
US12090064B2 (en) 2022-03-01 2024-09-17 Medos International Sarl Stabilization members for expandable intervertebral implants, and related systems and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1276555B1 (it) * 1995-04-28 1997-11-03 Angeletti P Ist Richerche Bio Antagonisti di interluchina-6 umana del tutto incapaci di formare un legame con gp 130, e loro uso per la preparazione di composizioni
IT1285790B1 (it) * 1996-09-24 1998-06-24 Angeletti P Ist Richerche Bio Adenovirus difettivi ricombinanti che codificano per mutanti di interleuchina 6 umana (hil-6) con attivita' antagonista o
GB9621095D0 (en) * 1996-10-09 1996-11-27 Imperial College Novel system
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation

Also Published As

Publication number Publication date
JP2003525906A (ja) 2003-09-02
SK12412002A3 (sk) 2002-12-03
DK1261367T3 (da) 2005-09-12
EP1261367A1 (en) 2002-12-04
KR100694005B1 (ko) 2007-03-12
CZ20022760A3 (cs) 2003-03-12
HUP0300117A3 (en) 2005-09-28
AU2000233235A1 (en) 2001-09-17
WO2001066131A1 (en) 2001-09-13
US20050090443A1 (en) 2005-04-28
ES2241583T3 (es) 2005-11-01
HUP0300117A2 (hu) 2003-04-28
EP1261367B1 (en) 2005-05-18
MXPA02008697A (es) 2003-04-14
KR20020079984A (ko) 2002-10-21
PT1261367E (pt) 2005-09-30
ATE295735T1 (de) 2005-06-15
DE60020269T2 (de) 2006-01-19
DE60020269D1 (de) 2005-06-23
CA2400711A1 (en) 2001-09-13
US7160860B2 (en) 2007-01-09

Similar Documents

Publication Publication Date Title
PL356846A1 (pl) Zastosowanie antagonistów interleukiny-6 do leczenia chorób scharakteryzowanych przez wysoki poziomaromatazy
MXPA05010830A (es) Metodos de tratamiento que usan agentes de enlace especificos de angiopoyetina-2 humana.
YU37304A (sh) Specifični agensi koji vezuju humani angiopoetin-2
MY151032A (en) Treatment of tnf? related disorders
SI1663242T1 (sl) 2,4-pirimidindiaminske spojine in uporabe kot antiproliferativna sredstva
MXPA03011761A (es) Un nuevo superantigeno disenado para terapia humana.
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
GB0111186D0 (en) Novel compounds
MXPA05005398A (es) Meta para terapia de deterioro cognitivo.
MXPA04006280A (es) Compuestos espiroazaciclicos como moduladores de receptor de monoamina.
GB0222495D0 (en) Compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
MXPA02011288A (es) Tioacetamidas substituidas.
MXPA04003796A (es) Tioacetamidas sustituidas.
MXPA04003674A (es) Uso mejorado de compuesto antitumoral en terapia de cancer.
IL163026A (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
GB0320320D0 (en) Novel compounds
GB0326633D0 (en) Therapeutic agents
MXPA05011699A (es) Inhibidores de la bomba de protones para el tratamiento de trastornos del abdomen inferior.
TR200200278T2 (tr) Kalsilitik bileşimler
AU2001233917A1 (en) Bcmp-7 as marker for diagnosis of breast cancer
MXPA04001986A (es) Composiciones y metodos para el tratamiento de enfermedades relacionadas a la inmunidad.
TW200726763A (en) Novel compound
EP1303300A4 (en) COMPOSITIONS AND METHODS FOR TREATING CANDIDIASIS
IL181713A0 (en) Use of il-17f for the treatment and/or prevention of neurological diseases

Legal Events

Date Code Title Description
VOID Decisions declaring the decisions on the grant of the patent lapsed